NO921973L - Diltiazen-formulering - Google Patents

Diltiazen-formulering

Info

Publication number
NO921973L
NO921973L NO92921973A NO921973A NO921973L NO 921973 L NO921973 L NO 921973L NO 92921973 A NO92921973 A NO 92921973A NO 921973 A NO921973 A NO 921973A NO 921973 L NO921973 L NO 921973L
Authority
NO
Norway
Prior art keywords
diltiazem
formula
directed
mixture
formulation
Prior art date
Application number
NO92921973A
Other languages
English (en)
Other versions
NO921973D0 (no
Inventor
Dennis L Hendrickson
Dan C Dimmitt
Mark S Williams
Paul F Skultety
Michael J Baltezor
Original Assignee
Marion Merrell Dow Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marion Merrell Dow Inc filed Critical Marion Merrell Dow Inc
Publication of NO921973D0 publication Critical patent/NO921973D0/no
Publication of NO921973L publication Critical patent/NO921973L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Foreliggende oppfinnelse er rettet mot en diltiazemformulering egnet for en endagsadministrering. For- muleringen inneholder en blanding av diltiazemperler som har to forskjellige oppløsningsprofiler.
NO92921973A 1991-05-20 1992-05-19 Diltiazen-formulering NO921973L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70256791A 1991-05-20 1991-05-20

Publications (2)

Publication Number Publication Date
NO921973D0 NO921973D0 (no) 1992-05-19
NO921973L true NO921973L (no) 1992-11-23

Family

ID=24821752

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921973A NO921973L (no) 1991-05-20 1992-05-19 Diltiazen-formulering

Country Status (17)

Country Link
EP (1) EP0514814B1 (no)
JP (1) JP3804029B2 (no)
KR (1) KR100244010B1 (no)
AT (1) ATE147982T1 (no)
AU (1) AU653223B2 (no)
CA (1) CA2068980A1 (no)
DE (1) DE69216910T2 (no)
DK (1) DK0514814T3 (no)
ES (1) ES2099764T3 (no)
FI (1) FI922270A7 (no)
GR (1) GR3022927T3 (no)
IE (1) IE921603A1 (no)
IL (1) IL101896A (no)
NO (1) NO921973L (no)
NZ (1) NZ242730A (no)
TW (1) TW265267B (no)
ZA (1) ZA923474B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
EP0717625B1 (en) * 1993-09-08 2002-06-12 Pharmacy and Therapeutic Advisory Consultancy Ltd. A method of treating liver disease and like indications with vasodilating agents
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
PT1009387E (pt) 1997-07-02 2006-08-31 Euro Celtique Sa Formulacoes estabilizadas de libertacao controlada de tramadol
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
WO1999038507A1 (en) * 1998-01-30 1999-08-05 David George Le Couteur Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
MXPA01004381A (es) * 1998-11-02 2005-09-08 Elan Corp Plc Composicion de multiparticulado de liberacion modificada.
AU2002256092C1 (en) * 2001-04-05 2009-10-15 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
CA2547137A1 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US7866376B2 (en) 2007-10-29 2011-01-11 Fu Zhun Precision Industry (Shen Zhen) Co., Ltd. Heat dissipation device with U-shaped and S-shaped heat pipes
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN114425046B (zh) * 2021-12-16 2023-10-20 南通联亚药业股份有限公司 一种盐酸地尔硫卓缓释胶囊

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
EP0225085A1 (en) * 1985-11-13 1987-06-10 ELAN CORPORATION, Plc Controlled absorption pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
DE3856555T2 (de) * 1987-10-16 2004-04-29 Elan Corp. Plc Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
SE8902699D0 (sv) * 1989-08-09 1989-08-09 Lejus Medical Ab Diltiazem containing pharmaceutical compositios

Also Published As

Publication number Publication date
ES2099764T3 (es) 1997-06-01
GR3022927T3 (en) 1997-06-30
FI922270L (fi) 1992-11-21
AU1632692A (en) 1992-11-26
IL101896A0 (en) 1992-12-30
AU653223B2 (en) 1994-09-22
DE69216910T2 (de) 1997-05-22
EP0514814B1 (en) 1997-01-22
JPH05178747A (ja) 1993-07-20
ZA923474B (en) 1993-01-27
FI922270A7 (fi) 1992-11-21
DE69216910D1 (de) 1997-03-06
JP3804029B2 (ja) 2006-08-02
NO921973D0 (no) 1992-05-19
IL101896A (en) 1996-08-04
CA2068980A1 (en) 1992-11-21
KR100244010B1 (ko) 2000-03-02
NZ242730A (en) 1994-09-27
FI922270A0 (fi) 1992-05-19
TW265267B (no) 1995-12-11
KR920021150A (ko) 1992-12-18
ATE147982T1 (de) 1997-02-15
IE921603A1 (en) 1992-12-02
DK0514814T3 (da) 1997-02-10
EP0514814A1 (en) 1992-11-25

Similar Documents

Publication Publication Date Title
NO921973L (no) Diltiazen-formulering
DK0640086T3 (da) Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
FI905602A7 (fi) Täysivärinen kolmiulotteinen projektionäyttö
NO894712D0 (no) Organopolysiloksan-blanding for dannelse av en sperrefilm.
DE69406529D1 (de) Neue kristalline form einer dem vitamin d analogen verbindung
ES8600306A1 (es) Un procedimiento para la preparacion de derivados de penem-2-metil sustituidos.
FI925633A0 (fi) Foerfarande foer framstaellning av en farmaceutisk sammansaettning som selektivt saenker lipidnivaon i blodet
ES2133315T3 (es) Nuevos esteroides.
CO4950531A1 (es) Analogos de la vitamina d3 composciiones farmaceuticas que los contienen
NO903920L (no) Fremgangsmaate for fremstilling av en isomerblanding.
DK0415766T3 (da) Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi
MX9302116A (es) Compuestos azabiciclo.
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
NO863114L (no) Kapsling som muliggjoer passiv blanding av et fordelaktig middel med en fortynner.
DE69230224D1 (de) Potenzierung von nmda-antagonisten
DK4687D0 (da) Anvendelse af esterforbindelser som temporaert mikrobicid
GR880100869A (el) Μέ?οδος παρασκευής παραγώγων υποκατεστημένου στυρολίου.
ES2021515A6 (es) Procedimiento para la preparacion de compuestos derivados de isotiazolo-piridona azetidinil substituidos.
MX9302878A (es) Procedimiento para la preparacion de un diaminodiol substituido.
GR900100109A (el) Διουρητικοι παραγοντες κυκλοαλκυλο-υποκατεστημενης γλουταραμιδης.
NO922544D0 (no) Tiksotrop blanding med foroekt opploeselighet av welangummii etylenglykoll
ES2010668B3 (es) Procedimiento de preparacion de derivados de 5-fenil-1,4,5,6-tetrahidropirimidina.
ES2052483T1 (es) Nuevos derivados del 3,3,5-trimetilciclohexanol, su procedimiento de preparacion asi como las composiciones terapeuticas que los contienen.
ES465216A1 (es) Un procedimiento para la preparacion de d-homoesteroides.
SE9502507L (sv) Belysningsanordning för att minimera förekomsten av reflexer vid bildskärmsarbete